HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Axonal transport plays a crucial role in mediating the axon-protective effects of NmNAT.

Abstract
Deficits in axonal transport are thought to contribute to the pathology of many neurodegenerative diseases. Expressing the slow Wallerian degeneration protein (Wld(S)) or related nicotinamide mononucleotide adenyltransferases (NmNATs) protects axons against damage from a broad range of insults, but the ability of these proteins to protect against inhibition of axonal transport has received little attention. We set out to determine whether these proteins can protect the axons of cultured hippocampal neurons from damage due to hydrogen peroxide or oxygen-glucose deprivation (OGD) and, in particular, whether they can reduce the damage that these agents cause to the axonal transport machinery. Exposure to these insults inhibited the axonal transport of both mitochondria and of the vesicles that carry axonal membrane proteins; this inhibition occurred hours before the first signs of axonal degeneration. Expressing a cytoplasmically targeted version of NmNAT1 (cytNmNAT1) protected the axons against both insults. It also reduced the inhibition of transport when cells were exposed to hydrogen peroxide and enhanced the recovery of transport following both insults. The protective effects of cytNmNAT1 depend on mitochondrial transport. When mitochondrial transport was inhibited, cytNmNAT1 was unable to protect axons against either insult. The protective effects of mitochondrially targeted NmNAT also were blocked by inhibiting mitochondrial transport. These results establish that NmNAT robustly protects the axonal transport system following exposure to OGD and reactive oxygen species and may offer similar protection in other disease models. Understanding how NmNAT protects the axonal transport system may lead to new strategies for neuroprotection in neurodegenerative diseases.
AuthorsCheng Fang, Helena Decker, Gary Banker
JournalNeurobiology of disease (Neurobiol Dis) Vol. 68 Pg. 78-90 (Aug 2014) ISSN: 1095-953X [Electronic] United States
PMID24787896 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Neuroprotective Agents
  • Oxidants
  • Hydrogen Peroxide
  • NMNAT1 protein, rat
  • Nicotinamide-Nucleotide Adenylyltransferase
  • Glucose
Topics
  • Animals
  • Axonal Transport (drug effects, physiology)
  • Axons (drug effects, physiology)
  • Cells, Cultured
  • Disease Models, Animal
  • Embryo, Mammalian
  • Female
  • Glucose (deficiency)
  • Hippocampus (cytology)
  • Hydrogen Peroxide (pharmacology)
  • Hypoxia (pathology)
  • Male
  • Mitochondria (metabolism, pathology)
  • Neurons (drug effects)
  • Neuroprotective Agents (pharmacology)
  • Nicotinamide-Nucleotide Adenylyltransferase (pharmacology)
  • Oxidants (pharmacology)
  • Rats
  • Wallerian Degeneration (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: